In a deal aimed at slashing the US giant's tax bill, Shire Pharmaceuticals has accepted a 32-billion ( (Dollar) 54-billion, 40-billion-euro) takeover bid from AbbVie, the two companies announced on Friday. The takeover, priced with a 53.0-percent premium for Shire stock, comes after Shire, based in Ireland, reversed its opposition to a deal earlier this week. "The boards of AbbVie and Shire are pleased to announce that they have reached agreement on the terms ...Sunday 20 July 2014
Drugmaker Shire Agrees to (Dollar) 54-Billion Takeover from AbbVie
In a deal aimed at slashing the US giant's tax bill, Shire Pharmaceuticals has accepted a 32-billion ( (Dollar) 54-billion, 40-billion-euro) takeover bid from AbbVie, the two companies announced on Friday. The takeover, priced with a 53.0-percent premium for Shire stock, comes after Shire, based in Ireland, reversed its opposition to a deal earlier this week. "The boards of AbbVie and Shire are pleased to announce that they have reached agreement on the terms ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment